Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome

@nicupodcast @ADC_FN Certainty, there is benefit with multiple doses of surfactant https://t.co/azG6VQJ06a But, strictly speaking in trial context the doses administered in two major trials were total 3 (at birth, 12 h, & 24 h). Outside this context,